Increasing Changes for Commercialisation of Research: The Implant Systems Experiment

Dr. John Parker (CTO, Implant Systems, NICTA)

NICTA SEMINAR Big Picture Series -- RSVP crlevents@nicta.com.au

DATE: 2010-04-07
TIME: 12:15:00 - 13:30:00
LOCATION: NICTA - 7 London Circuit
CONTACT: JavaScript must be enabled to display this email address.

ABSTRACT:
The power of modern electronics and computer science has far exceeded our ability to deploy them in active medical devices. Complex systems for sensing and controlling and affecting a therapeutic biological response are easily demonstrated on the bench but defy continual operation inside the body and as a result even the most technically advanced implantable devices remain very simple.

The architecture of neuro-modulation systems has not changed in 25 years despite the technical advances in allied disciplines. This stagnation is due to a lack of a number of platform technologies, tissue interfaces, packaging and scalable system architectures. It is the development of these technologies, which are the focus of the research effort at NICTA as Implant Systems group.

BIO:
Dr Parker spearheads NICTA as Implant Technologies Group. He has been an Executive Director and CTO of Cochlear Limited and is an experienced director of both listed and non listed companies and CRCs